FdaApplication
ANDA 215615
Identifiers
- fda_app_no: ANDA215615
Properties
| Property | Value |
|---|---|
| applicant_name | TAGI PHARMA INC |
| application_type | ANDA |
| approval_date | 2022-10-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHAZOLAMIDE | METHAZOLAMIDE | 25MG | TABLET;ORAL |
| METHAZOLAMIDE | METHAZOLAMIDE | 50MG | TABLET;ORAL |
2 products